How weather and community practices affect mosquito- and tick-borne infections
Official title: Project 2 - Center for Transformative Infectious Disease Research (CTIDR)
Funded at Cornell University · NIH-11193940 · Data updated 2026-11-12
This project looks at how changes in weather and local behaviors affect the spread of infections carried by mosquitoes and ticks in communities at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $234,233 |
| NIH project number | 5P20AI186093-02 |
| Project ID | NIH-11193940 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are people living in or near regions affected by mosquito- or tick-borne diseases who are willing to share health information, participate in community surveys, or provide samples if requested.
✕Less likely to help
People who live far from the project's field sites or have no risk of exposure to vector-borne infections are unlikely to benefit directly.
What this research studies
Researchers will collect field samples from frontline sites where mosquito- and tick-borne infections are emerging and combine pathogen genomics with environmental data. They will use weather and climate information plus lab studies of vectors to build models that predict when and where transmission is most likely. The team will work with community partners to include local behaviors and qualitative information into those models. This groundwork is intended to support future tests of targeted interventions to reduce infections.
Why it matters
Potential benefit: If successful, the work could help communities predict outbreaks and design targeted interventions that reduce mosquito- and tick-borne infections.
How similar studies have gone: Past work using weather data, vector surveillance, and genomics has helped predict outbreaks, but combining those methods with community-based qualitative data is a newer and less-tested approach.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Goodman, Laura Brunengraber — Cornell University
- Study coordinator: Goodman, Laura Brunengraber
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.